Clinical Scorecard: Alterations in Regional Brain Structures Observed in Diabetes, Excluding Prediabetes
At a Glance
Category
Detail
Condition
Diabetes Mellitus (DM) and Prediabetes (PreDM)
Key Mechanisms
Hyperglycemia-induced microvascular dysfunction leading to brain volume changes and white matter hyperintensity (WMH)
Target Population
Adults older than 50 years with DM, PreDM, or normal glycemic status
Care Setting
Community-based clinical research and neuroimaging assessment
Key Highlights
Significant gray matter volume (GMV) reductions observed in DM, especially in motor and coordination brain regions (bilateral cerebellum, right precentral gyrus, left postcentral gyrus).
Increased tract-specific white matter hyperintensity (WMH) index found in DM across multiple white matter tracts, correlating positively with glycemic levels.
No significant brain structural changes or WMH progression detected in the prediabetic group compared to controls.
Guideline-Based Recommendations
Diagnosis
Use World Health Organization 1999 criteria for diagnosing DM and PreDM based on fasting and postprandial blood glucose levels.
Employ MRI with voxel-based morphometry (VBM) and FLAIR imaging to assess brain structural changes and WMH.
Management
Prioritize prevention of diabetes to mitigate cerebral structural damage and cognitive decline.
Monitor cognitive function and motor performance in patients with DM using tools like Montreal Cognitive Assessment (MoCA), gait speed, and grip strength tests.
Monitoring & Follow-up
Regularly assess glycemic control to evaluate risk of WMH progression and brain atrophy.
Conduct longitudinal neuroimaging and cognitive assessments to track cerebral changes in DM patients.
Risks
DM is associated with accelerated cognitive decline and increased risk of dementia due to microvascular brain damage.
Prediabetes does not show significant brain structural alterations, indicating possible brain resilience at early metabolic dysregulation stages.
Patient & Prescribing Data
Adults aged >50 years with diagnosed diabetes or prediabetes
Effective glycemic control and diabetes prevention may protect against brain volume loss and white matter damage, preserving cognitive and motor functions.
Clinical Best Practices
Incorporate comprehensive neuroimaging (T1-weighted MRI and FLAIR) in research or clinical evaluation of diabetic patients to detect early brain changes.
Use cognitive and motor function tests (MoCA, gait speed, grip strength) as adjuncts to monitor neurological impact of diabetes.
Focus on early diabetes prevention strategies rather than expecting gradual brain decline beginning in prediabetes.
